Aaron A. R. T., Canaday D. H., Henry Boom W., & Harding C. V., 2004. Bacterial heat shock proteins romote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8 + T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. The Journal of Immunology, 172, 5277-5286.

Abad A. R., Cease K. R., & Blanchette R. A., 1987. A rapid technique using epoxy resin Quetol 651 to prepare woody plant tissues for ultrastructural study. Canadian Journal of Botany, 66, 677-682.

Allez M., & Mayer L., 2004. Regulatory T cells: peace keepers in the gut. Inflammatory Bowel Diseases, 10, 666-676.

Anderson N., 2004. Probiotics market face EU challenge. Breaking News on Supplements, Nutrition & Healthy Foods. 08 Janvier, p.1

Ang D. K., Libereck D., Skowyra M. Z., & Georgopoulos C., 1991. Biological role and regulation of the universally conserved heat shock proteins. Journal of Biological Chemistry, 266, 24233-24236 .

Arbour N., Tremblay P., & Oth D., 1996. N-formyl-methionyl-leucyl-phenylalanine induces and modulates IL-1 and IL-6 in human PBMC. Cytokine, 8, 468-475 .

Arroyo L., Cotton L. N., & Martin J. H., 1995. ACM agar-a composite medium for selective enumeration of Bifidobacterium longum . Cultural Dairy Products Journal, 2, 12-15.

Asahara T., Nomoto K., Shimizu K., Watanuki M., & Tanaka R., 2001a. Increased resistance of mice to Salmonella enterolitica serovar Typhimurium infection by symbiotic administration of Bifidobacteria and transgalactosylated oligosaccharides. Journal of Applied Microbiology, 91, 985-996.

Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., & Takeda Y., 2004. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7 . Infection and Immunity, 7, 2240-2247.

Asahara T., Shimizu K., Nomoto K., Watanuki M., & Tanaka R., 2001 b. Antibacterial effect of fermented milk containing Bifidobacteria breve , Bifidobacteria bifidum and Lactobacillus acidophilus against indigenous Escherichia coli infection in mice. Microbial Ecology in Health and Disease, 13, 16-24.

Attouri N., Bouras M., Tome D., Marcos A., & Lemonnier D., 2002. Oral ingestion of lactic acid bacteria by rats increases lymphocyte proliferation and interferon-γ production. British Journal of Nutrition, 87, 367-373.

Baek S. H., Seo J. K., Chae C. B., Suh P. G., & Ryu S. H., 1996. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. Journal of Biological Chemistry, 271,8170-8165.

Ballas Z. D., Rasmussen W. L., & Krieg A. M., 1996. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. Journal of Immunology, 157, 1840-1847.

Ballongne J., 1993. Bifidobacteria and probiotic action. In Lactic acid bacteria . Ed. Salminen A. and Von Wright A., 357-428 .

Bartosch S., Woodmansey E. J., Paterson J. C., McMurdo M. E., & Macfarlane G. T., 2005. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clinical Infectious Diseases, 40, 28-37.

Baumgart D. C., & Dignass A. U., 2002. Intestinal barrier function. Current Opinion in Clinical Nutrition & Metabolic Care, 5, 685-94.

Bautista-Garfias C.R., Ixta-Rodriguez O., Martinez-Gomez F., Lopez M.G., & Aguilar-Figueroa B. R., 2001. Effect of viable or dead Lactobacillus casei organisms administered orally to mice on resistance against Trichinella spiralis infection. Parasite, 8, 226-228.

Berg R. D., 1998. Probiotics, prebiotics or ‘’conbiotics’’. Trends in Microbiology, 6, 89-92.

Bergmaier D., Lacroix C., Guadalupe Macedo M., & Champagne C. P., 2001. New method for exopolysaccharide determination in culture broth using stirred ultrafiltration cells. Applied Microbiology and Biotechnology, 57, 401-406.

Bergmaier D., Champagne C. P., Lacroix C., 2003. Exopolysaccharide production during batch cultures with free and immobilized Lactobacillus rhamnosus RW-9595M. Journal of Applied Microbiology, 95, 1049-57.

Beveridge T., & Graham L., 1991. Surface layers of bacteria. Microbiology Review, 55, 684-705.

Bjorksten B., 2004. Effects of intestinal microflora and the environment on the development of asthma and allergy. Springer Seminras in Immunopathology, 25, 257-270.

Blaut M., 2002. Relationship of prebiotics and food to intestinal microflora. European Journal of Nutrition, 41, 11- 16.

Blehaut H., Massot J., Elmer G. W., & Levy R. H., 1989. Disposition kinetics of Saccharomyces boulardii in man and rat. Biopharmaceutics and Drug Disposition, 10, 353-364.

Blum S., Delneste Y., Alvarez S., Haller D., Perez P. F., Bode Ch. Hammes W. P., Pfeir A. M. A., & Schiffrin E. J., 1999. Interactions between commensal bacteria and mucosal immunocompetent cells. International Dairy Journal , 9 , 63-68.

Bokken Gertie C. A. M., Corbee Ronald J., Knapen F. V, & Bergwer A. A., 2003. Immunochemical detection of Salmonella group B, D and E using an optical surface plasmon resonance biosensor. FEMS Microbiology Letters, 222, 75-82.

Bolin I., Lonroth H., & Svennerholm A. M., 1995. Identification of Helicobacter pylori by immunological dot blot method based on reaction of a species-specific monoclonal antibody with a surface-exposed protein. Journal of Clinical Microbiology, 33, 381-384.

Borriello S. P., Hammes W. P, Holzapfel W., Marteau P., Schrezenmeir J., Vaara M., & Valtonen V., 2003. Safety of probiotics that contain Lactobacilli or Bifidobacteria. Clinical Infectious Diseases, 36, 775-780.

Borruel N., Carol M., Casellas F., Antolín M., de Lara F., Espín E., Naval J., Guarner F., & Malagelada J. R., 2002. Increased mucosal tumour necrosis factor a production in Crohn’s disease can be down regulated ex vivo by probiotic bacteria. Gut, 51, 659-664.

Bot A., Smith K. A., & Von Herrath M., 2004. Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defence and immune pathology. DNA and Cell Biology, 23, 341-350.

Brandtzaeg P., 1996. History of oral tolerance and mucosal immunity. Annals of the New York Academy of Sciences, 778, 21-27.

Brandtzaeg P., 2002. Current understanding of gastrointestinal immunoregulation and its relation to food allergy. Annual of New York Academy of Sciences, 964, 13-45.

Brassard D., 1997. Bactéries lactiques et santé. Centre de recherche de l’Académie d’agriculture francaise, 83, 35-40.

Brubaker J. O., Li Q, Tzianabos A. O., Kasper D. L., & Finberg R.W., 1999. Mitogenic activity of purified capsular polysaccharide A from Bacteroides fragilis : differential stimulatory effect on mouse and rat lymphocytes in vitro . Journal of Immunology, 16, 2235-2242.

Bukowska H., Pieczul-Mroz J., Jastrze¸bska M., Chełstowski K., & Naruszewicz M., 1998. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis, 137, 437–438.

Bunthof C. J., Bloemen K., Breeuwer P., Rombouts F. M., Abee T., 2001. Flow cytometric assessment of viability of lactic acid bacteria. Applied and Environmental Microbiology, 67, 2326-2335.

Butt T., Malik H. S., Abbassi S. A., Ahmad R. N., Mahmood A., Karamat K. A., & Anwar M., 2004. Genus and species-specific IgG and igm antibodies for pulmonary tuberculosis. Journal of College of Physicians and Surgeons Pakistan., 14, 105-107.

Calder P. C., & Samantha K., 2002. The immune system: a target for functional foods? British Journal of Nutrition, 88, 165-176.

Cano P. G., & Perdigon G., 2003. Probiotics induce resistance to enteropathogens in a re-nourished mouse model. Journal of Dairy Research, 70, 433-440.

Carlisle M. S., McGregor D. D., & Appleton J. A., 1991. The role of the antibody Fc region in rapid expulsion of Trichinella spiralis in suckling rats. Immunology, 74, 552-558.

Casadevall A., Dadachova E., & Pirofski L. A., 2004. Passive antibody therapy for infectious diseases. Nature Reviews| Microbiology, 2, 695- 703.

Castellino F., Boucher P. E., Eichelberg K., Mayhew M., Rothman J. E., Houghton A. N., & Germain, R. N., 2000. Receptor-mediated uptake of antigen/heat shock protein complexe results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. Journal of Experimental Medicine, 191, 1957 .

Cerning J., Renard C. M. G. C., Thibault J. F., Bouillanne C., London M., Desmazeaud M., & Topisirovic L., 1994. Carbon source requirements for exopolysaccharides production by Lactobacillus casei CG11 and partial structure analysis of the polymer. Applied and Environmental Microbiology, 60, 3914-3919.

Chabot S., Yu H.. L., De Lseleuc L., Cloutier D., Van Calstern M..R.., Lessard M., Roy D., Lacroix M., & Oth D., 2001. Exopolysaacharides from Lactobacillus rhamnosus RW-9595M stimulate TNF, IL-6 and IL-12 in human and mouse cultured immunocompetent cells, and IFN-γ in mouse splenocytes. Lait, 81, 683-697 .

Chadwick V. S., Mellor D. M., Myers D. B., Selden A. C., Keshavarzian A., Broom M. F., & Hobson C. H., 1988. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo . Scandinavian Journal of Gastroenterol., 23, 121-128.

Chamberlain P., 2002. Immunogenicity of therapeutic proteins Part 1: Causes and clinical manifestations of immunogenicity. The Regulatory Review, 5, 4-9.

Champomier-Verges M. C., Maguin E., Mistou M. Y., Anglade P., & Chich J. F., 2002. Lactic acid bacteria and proteomics: current knowledge and perspectives. Journal of Chromatography, 771, 329-342.

Chaudhary P. M., Ferguson C., Nguyen V., Nguyen O., Massa H. F., Eby M., Jasmin Trask A, B. J, Hood L., & Nelson P. S., 1998. Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: evidence for a multi-gene receptor family in humans. Blood, 9, 4020-4027 .

Chen R. M., Wu J. J., Lee S. C., Huang A. H., & Wu H. M., 1999. Increase of intestinal Bifidobaterium and suppression of coliform bacteria with short-term yogurt ingestion. Journal of Dairy Sciences, 82, 2308-2314.

Chiang B. L., Sheih Y. H., Wang L. H., Liao C. K., & Gill H. S., 2000. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium ( Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. European Journal of Clinical Nutrition, 54, 849-855.

Christensen H. R., Frokiaer H., & Pestka J. J., 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. Journal of Immunology, 168, 171-178.

Chua-Intra, B., Peerapakorn, S., Davey, N., Jurcevic, S., Busson, M., Vordermeier, H. M., Pirayavaraporn, C., & Ivanyi, J., 1998. T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts . Infection and Immunity, 66, 4903-4909.

Chukeatirote E., 2003. Potential use of probiotics. Songklanakarin Journal of Science and Technology, 25, 275-282.

Coconier, M. H., Bernet M F., Kernéis S., Chauvière G., Fourniat J., & Servin A. L., 1993. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiology Letters, 110, 299-306.

Comerford I., & Nibbs R. J., 2005. Post-translational control of chemokines: a role for decoy receptors? Immunology Letters, 96, 163-174.

Corsetti A., De Angelis M., Dellaglio F., Paparella A., Fox P.F., Settanni L., Gobbetti M., 2003. Characterization of sourdough lactic acid bacteria based on genotypic and cell-wall protein analyses. Journal of Applied Microbiology, 94, 641-654.

Cross M. L., Stevenson L. M., & Gill H. S., 2001. Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria. International Immunopharmacology, 1, 891-901.

Cummings J. H., Gibson G. R., & Macfarlane G. T., 1989. Quantitative estimates of fermentation in the hind gut of man. Acta Veterinaria Scandinavica, 86, 76-82.

Cunningham-Rundles S., Ahrne S., Bengmark S., Johann-Liang R., Marshall F., Metakis L., Califano C., Dunn A. M., Grassey C., Hinds G., & Cervia J., 2000. Probiotics and immune response. American Journal of Gastroenterology, 95, 22-25.

D’Andrea A., Aste-Amezaga M., Valiante N. M., Ma X, Kubin M., & Trinchieri G., 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor / IL-12 synthesis in accessory cells. Journal of Experimental Medecine, 178, 1041-1048.

Dabbagh K., & Lewis D. B., 2003. Toll-like receptors and T-helper-1/T-helper-2 responses. Current Opinion in Infectious Diseases, 16, 199-204.

De Angelis M., Di Cagno R., Huet C., Crecchio C., Fox P. F., & Gobbetti M., 2004. Heat shock response in Lactobacillus plantarum . Applied and Environmental Microbiology, 70, 1336-1346.

De Roos N. M., & Katan M. B., 2000. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis : a review of papers published between 1988 and 1998. American. Journal of Nutrition, 71, 405-411.

De Simone C., Bianchi Salvadori B., Jirillo E., Baldinelli L., Bitonti F., & Vesely R., 1989. Modulation of immune activities in humans and animals by dietary lactic acid bacteria. In: Chandan R. C., editor. Yogurt Nutritional and Health Properties (pp. 201-13). London: John Libbey Press.

De Simone C., Vesely R., Bianchi Salvadori B., & Jirillo E., 1993. The role of probiotics in modulation of the immune system in man and in animals. International Immunotherapy, 9, 23-28.

De Vries W. & Stouthamer A. H., 1967. Fermentation of glucose, lactose, galactose, mannitol and xylose by bifidobacteria. Journal of Bacteriology, 96, 472-478.

De Waard R., Claassen E., Bokken G. C. A. M., Buiting B., Garssen J., & Vos J. G., 2003. Enhanced immunological memory responses to Listeria monocytogenes in rodents, as measured by delayed-type hypersensitivity (DTH), adoptive transfer of DTH, and protective immunity, following Lactobacillus casei Shirota ingestion. Clinical and diagnostic laboratory immunology, 10, 59-65.

De Wall Malefyt R., Abrams J., Bennet B., Figdor C. G., & De Vries J. E., 1993. Interleukin 10 (IL-10) inhibits cytokines synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medecine, 174, 1209-1220.

Delcour J., Ferain T., Deghorain M., Palumbo E., & Hols P., 1999. The biosynthesis and functionality of the cell wall of lactic acid bacteria. Antonie van Leeuwenhoek, 76, 159-184.

Dijkstra A. J., Alber G., & Keck W., 1997. The naturally occurring muramylpeptide G(Anh)Mtetra protects mice against Escherichia coli septic shock and induces neutrophilia in vivo . In Arnoud Jan Dijkstra, editor . The lytic transglycosylase family of Escherichia coli : in vitro activity versus in vivo function (pp.139-150). University Library Groningen.

Dinakar P., & Mistry V. V., 1994. Growth and viability of Bifidobacterium bifidum in cheddar cheese. Journal of Dairy Science, 77, 2854-2864.

Dobrotina N. A., Ezhova G. P., Kazatskaia Z. A., Ladygina G. N., & Kurova M. V.,1992. The comparative characteristics of the biological and immunomodulating activities of enzyme preparations of microbial origin. Nauchnye Doki Vyss Shkoly Biol Nauki, 2, 90-96.

Dong X., Cheng G., & Jian W., 2000. Simultaneous identification of five Bifidobacterium species isolated from human beings using multiple PCR primers. Systematic and Applied Microbiology, 23, 386-390.

Drouault S., Corthier G., Ehrlich S. D., Renault P., 1999. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Applied and Environmental Microbiology, 65, 4881-4886.

Dubois M., Gilles K. A., Hamilton J. K., & Reberts P. A., 1956. Colorometric method for determination of sugars and related substances. Analytical Chemistry, 28, 350-356.

Ducluzeau R., Rambaud P., & Bernasconi P., 1984. Flore et écosystème intestinal . Edition Scientifique Biocodex.

Dunne C., O'Mahony L., Murphy L., Thornton G., Morrissey D., O'Halloran S., Feeney M., Flynn S., Fitzgerald G., Daly C., Kiely B., O 'Sullivan G. C., Shanahan F., & Collins J. K, 2001. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. American Journal of Clinical Nutrition, 73, 386-392.

Ebina T., Ogata N., & Murata K., 1995. Antitumor effect of Lactobacillus bulgaricus 878R. Biotherapy, 9, 65-70.

Echchannaoui H., Frei K., Schnell C., Leib S. L., Zimmerli W., & Landmann R., 2002. Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. Journal of Infectious Dieases, 186, 798-806.

Erickson K. L., & Hubbard N.E., 2000. Probiotic immunomodulation in health and disease. Journal of Nutrition, 130, 403-409.

Ernst S., Lange C., Wilbers A., Goebeler V., Gerke V., & Rescher U., 2004. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family1. Journal of Immunology, 172, 7669-7676 .

Faber E. J., Haak M. J., Kamerling J. P., & Vliegenthart J. F. G., 2001. Structure of the exopolysaccharide produced by Streptococcus thermophilus S3 . Carbohydrate Research, 331, 173-182.

Fang H., Elina T., Heikki A., & Seppo S., 2000. Modulation of humoral immune response through probiotic intake. FEMS Immunology and Medical Microbiology, 29, 47-52.

Fernandez-Espla M., Garault P., Monnet V., & Rul F., 2000. Streptococcus thermophilus cell wall-anchored proteinase: release, purification, and biochemical and genetic characterization. Applied and Environmental Microbiology, 66, 4772-4778.

Flo T. H, Halaas O., Torp S., Ryan L., Lien E., Dybdahl B., Sundan A., & Espevik T., 2001. Differential expression of Toll-like receptor 2 in human cells. Journal of Leukocyte Biology, 69, 474-481.

Fooks L. J., & Gibson G. R., 2002. Probiotics as modulators of the gut flora. British Journal of Nutrition, 88, 39-49.

Freer R. J., Day A. R., Muthukumaraswamy N., Pinon D., Wu A., Showell H. J., & Becker E. L., 1982. Formyl peptide chemoattractants: a model of the receptor on rabbit’s neutrophils. Biochemistry 21, 257-263.

Fu H., Dahlgren C., & Bylund J., 2003. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy, 47, 2545-2550.

Fuller R., & Perdigon G., 2000. Probiotics 3: Immunomodulation by the gut microflora and probiotics. Kluwer Academic Publishers, Dordrecth.

Fuller R., 1989. Probiotics in man and animals. Journal of Applied Bacteriology, 66, 365-378.

Gagnon M., Kheadr E. E., Le Blaya G., & Flissa I., 2004. In vitro inhibition of Escherichia coli O157:H7 by bifidobacterial strains of human origin. International Journal of Food Microbiology, 92, 69-78

Gatti M., Fornasari E., & Neviani E., 1997. Cell wall protein profiles of dairy thermophilic lactobacilli. Letters in Applied Microbiology, 25, 345-348.

Gavini F., Pourcher A. M., Nut C., Monget D., Romond C., Oger C., & Izard D., 1991. Phenotypic differentiation of bifidobacteria of human and animal origins. International Journal of Systematic Bacteriology, 41, 548-557.

Gibson G. R., & Wang X., 1994. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. Journal of Applied Bacteriology, 77, 412-420.

Gibson G. R., & Fuller R., 2000. Aspects of in vitro and in vivo research approaches directed toward identifying probiotics and prebiotics for human use. Journal of Nutrition, 130, 391-395.

Gibson G. R., & Roberfroid M. B., 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition, 125, 1401-1412.

Gill H. S., 1998. Stimulation of the immune system by lactic cultures. International Dairy Journal , 8, 535-44.

Gill H. S., Rutherfurd K. J., & Cross M. L., 2001. Dietary probiotic supplementation enhances natural killer activity in the elderly: An investigation of age-related immunological changes. Journal of Clinical Immunology, 21, 264-271 .

Gill H. S., Rutherfurd K. J., Prasad J., & Gopal P. K., 2000. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). British Journal of Nutrition, 83, 167-76.

Gobbetti M., Corsetti A., Smacchi E., Zocchetti A., & De Angelis M., 1998. Production of crescenza cheese by incorporation of Bifidobacteria. Journal of Dairy Science, 81, 37-47.

Godward G., Sultana K., Kailasapathy K., Peiris P., Arumugaswamy R., & Reynolds N., 2000. The importance of strain selection on the viability and survival of probiotic bacteria in dairy foods. Milchwissenschaft-Milk Science International, 55, 441- 445.

Gonzalez D., Tzianabos A. O., Genco C. A., & Gibson III F. C., 2003. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis- elicited oral bone loss in a murine model. Infection and immunity, 71, 2283-2287.

Gosselink M. P, Schouten W. R., van Lieshout L. M., Hop W. C., Laman J. D., & Ruseler-van Embden J. G., 2004. Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG. Disease of Colon and Rectum, 47, 876-884.

Gournier-château N., Larpent J. P., Castillanos M. I., & Larpent J. L., 1994. Les probiotiques en alimentation animale et humaine. Édition Technologie et documentation Lavoisier pp. 1-192, Paris, France.

Grill J. P., Crociani J., & Ballongue J., 1995. Characterization of fructose 6-phosphate phosphoketolases purified from Bifidobacterium species. Current Microbiology, 31, 49-54.

Grogono-Thomas R., Blaser M. J., Ahmadi M., & Newell D. G., 2003. Role of S-layer protein antigenic diversity in the immune responses of sheep experimentally challenged with Campylobacter fetus subsp fetus. Infection and Immunity, 71, 147-154.

Groleau P. E., Jimenez-Flores R., Gauthier S. F., & Pouliot Y., 2002. Fractionation of beta-lactoglobulin tryptic peptides by ampholyte-free isoelectric focusing. Journal of Agriculture and Food Chemistry, 50, 578-83.

Guandalini S., 2002. Use of Lactobacillus-GG in paediatric Crohn's disease. Digestive and Liver Disease, 3, 63-65.

Halassy B., Krstanovic M., Frkanec R., & Tomašie J., 2003. Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine, 21, 971-976.

Halpern M. D., Kurlander R. J., & Pisetsky D. S., 1996. Bacterial DNA induces murine interferon gamma production by stimulation of IL-12 and tumor necrosis factor-alpha. Cell. Immunology, 167, 72-78.

Hamann L., El-Samalouti V., Ulmer A. J., Flad H. D., & Rietschel E. T., 1998. Components of gut bacteria as immunomodulators. International Journal of Food Microbiology, 41, 141-154.

Hao W. L., & Lee Y. K., 2004. Microflora of the gastrointestinal tract: a review. Methods in Molecular Biology, 268, 491-502.

He F., Morita H., Ouwehand Arthur C., Hosoda M., Hiramatsu M., Kurisaki J. I., Isolauri E., Benno Y., & Salminen S., 2002. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium Strains. Microbiology and Immunology, 46, 781-785.

Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., & Takeda, K., 2000. A Toll-like receptor recognizes bacterial DNA. Nature (London), 408, 740-745.

Higashimura M., Mulder-Bosman B. W., Reich R., Iwasaki T., & Robin G. W., 2000. Solution properties of viilian, the exopolysaccharide from Lactococcus lactis subsp . cremoris SBT 0495. Biopolymers, 54, 143-158.

Hirayama K., & Rafter J., 2000. The role of probiotic bacteria in cancer prevention. Microbes and Infection, 2, 681-686.

Hobson C. H., Roberts E. C., Broom M. F., Mellor D. M., Sherriff R. M., & Chadwick V. S., 1990. Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria. Journal of Gastroenterology and Hepatology, 5, 32-37.

Hodgkin P. D., Rush J., Guett A., Bartell G., & Hasbold J., 1998. The logic of intercellular communication in the immune system. Fener Conference. Immunology and cell Biology, 76, 448- 453.

Hokeness K. L., Kuziel W. A., Biron C. A., & Salazar-Mather T. P., 2005. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-{alpha}/{beta}-induced inflammatory responses and antiviral defense in liver. Journal of Immunology, 174, 1549-1556.

Holzapfel W. H., Haberer P., Snel J., Schillinger U., & Huis in’t Veld J. H. J., 1998. Overview of gut flora and probiotics. International. Journal of Food Microbiology, 41, 85-101.

Hooper L. V., & Gordon J. I., 2001. Commensal host-bacterial relationships in the gut. Science, 292, 1115-1118.

Hoover Dallas G., 1993. Bifidobacteria: Activity and potential benefits. Food Technology, June, 120-124.

Hopkins M. J., Sharp R., & Macfarlane G. T., 2002. Variation in human intestinal microbiota with age. Digestive and Liver Diseases, 34, 12-18.

Hosono J. L., Amenati A., Natsume M., Hirayama M., Adachi T., & Kaminogawa S., 1997. Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4 . Bioscience, Biotechnology and Biochemistry, 61, 312-316 .

Houba V., Berger F. M., Dinarello C. A., Johnson A.G., Le J., Mauel J., Van der Meer J. W., Philippeaux M. M., Vilcek J., & Vogels M. T., 1992. Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilis . Development in Biological Standardization, 77, 121-128.

Hughes D. B., & Hoover D. G., 1995. Viability and enzymatic activity of bifidobacteria in milk. Journal of Dairy Sciences, 78, 268-276.

Hussain R., Shahid F., Zafar S., Dojki M., & Dockrell H. M., 2004. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: implications for development of vaccine and diagnostic reagents. Immunology, 111, 462-471.

Ibnou-Zekri N., Blum S., Schiffrin E. J., & von der Weid T., 2003. Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro . Infection and immunity, 71, 1428-1436.

Iliev I. D., Kitazawa H., Shimosato T., Katoh S., Morita H., He F., Hosoda M., Saito T., 2005. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cellular Microbiology, 7, 403-414 .

Iribe H., Koga T., Onoue K., Kotani S., Kusumoto S., & Shiba T., 1981. Macrophage-stimulating effect of synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T cell activating monokines. Cellular Immunology, 64, 73-83.

Ishibashi N., & Shimamura S., 1978. Bifidobacteria: research and development in Japon. Food Technology, 126-134.

Ishii K. J., Gursel I., Gursel M., & Klinman D. M., 2004. Immunotherapeutic utility of stimulatory and suppressive oligodeoxynucleotides. Current Opinion in Molecular Thermodynamic, 6, 166-174.

Isolauri E., Kirjavainen P. V., & Salminen S., 2002. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut, 50, 54-59.

Isolauri E., Salminen S., & Ouwehand A. C., 2004. Probiotics. Best Practice & Research Clinical Gastroenterology, 18, 299-313.

Isolauri E., Sütas Y., Kankaanpää P., Arvilommi H., & Salminen S., 2001. Probiotics: effects on immunity. American Journal of Clinical Nutrition, 73, 444-450.

Jain P. K., McNaught C. E., Anderson A. D., MacFie J., & Mitchell C. J., 2004. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus , Lactobacillus bul garicus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clinical Nutrition, 23, 441-445 .

Jiang T., Mustapha A., & Savaiano D. A., 1996. Improvement of lactose digestion in humans by ingestion of unfermented milk containing Bifidobacterium longum . Journal of Dairy Sciences, 79, 750-757.

Jijon H., Backer J., Diaz H., Yeung H., Thiel D., McKaigney C., De Simone C., & Madsen K., 2004. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology, 26, 1358-1373.

Kagnoff, M. F., & Eckmann L., 1997. Epithelial cells as sensors for microbial infection. Journal of Clinical Investigation, 100, 6-10.

Kaila K., & James C., 2000. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and cell Biology, 78, 80-88.

Kaila M., Isolauri E., Soppi E., Virtanen V., Laine S., & Arrilommi H. 1992. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a man lactobacilli strain. Pediatric Research, 32, 141-144.

Kailasapathy K., & Chin J., 2000. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunology and Cell Biology, 78, 80-88.

Kailasapathy K., 2002. Microencapsulation of probiotic bacteria: technology and potential applications. Current Issues in Intestinal Microbiology, 3, 39-48.

Kalka-Moll W. M., Tzianabos A. O., Bryant P. W., Niemeyer M., Ploegh H. L., & Kasper D. L., 2002. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. Journal of Immunology, 169, 6149-6153.

Kaminogawa S., 1996. Food allergy, oral tolerance and immunomodulation-Their molecular and cellular mechanisms. Bioscience Biotechnology and Biochemistry, 60, 1749-1756 .

Kankaanpa P., Sutasb Y., Salminena S., & Isolaurib E., 2003. Homogenates derived from probiotic bacteria provide down-regulatory signals for peripheral blood mononuclear cells. Food Chemistry, 83, 269-277.

Kaplan H., & Hutkins R., 2000. Fermentation of fructooligosaccharides by lactic acid bacteria and bifidobacteria. Applied and Environnemental Microbiology, 66, 2682-2684.

Kato I., Tanaka K., & Yokokura T. 1999. Lactic acid bacterium potently induces the production of interleukin-12 and interferon- by mouse splenocytes. International Journal of Immunopharmacology, 21, 121-131.

Kaur I. P., Chopra K., & Saini A., 2002. Probiotics: potential pharmaceutical applications. European Journal of Pharmaceutical Sciences, 15, 1-9.

Kawai T., Seki M., Hiromatsu K., Eastcott J. W., Watts G. F., Sugai M., Smith D. J., Porcelli S. A., & Taubman M. A., 1999. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. Journal of Immunology, 15, 3269-3278.

Kawakami K., 2003. Promising immunotherapies with Th1-related cytokines against infectious diseases. Journal of Infections and Chemotherapy, 9, 201-209 .

Kemp K., 2000. Cytokine-producing T cell subsets in human leishmaniasis. Archivum Immunologiale Therapiae Experimentalis (Warsz), 48, 173-176.

Kerr M. A., 1990. The structure and function of human IgA. Biochemistry Journal, 271, 285-296.

Kidd P., 2003. Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Alternative Medicine Review, 8, 223-246.

Kim J., Woo H. J., Kim Y. S., Kim K. H, & Lee H. J., 2003. Cell cycle dysregulation induced by cytoplasm of Lactococcus latis ssp. lactis in SNUC2A, a colon cancer cell line. Nutrition and Cancer, 46, 197-201.

Kim Y., Bae Y. S., Park J. C., Suh P. G., & Ryu S. H., 2001. The synthetic peptide, His-Phe-Tyr-Leu-Pro-Met, is a chemoattractant for Jukat T cells. Experimental and Molecular Medecine, 33, 257-262.

Kimura K., McCartney A. L., McConnell M. A., & Tannock G. W., 1998. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strains. Applied and Environmental. Microbiology, 63, 3394-3398.

Kirjavainen P. V., Elnezami H. S., Salminen S. J., Ahokas J. T., & Wright P. F. A., 1999. Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. s hermanii JS on mouse lymphocyte proliferation. Clinical and Diagnostic Laboratory Immunology, 6, 799–802.

Kitazawa H., Harata T., Uemura J., Saito T., Kaneko T., & Itoh T., 1998. Phosphate group requirement for mitogenic activation of lymphocytes by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii ssp. bulgaricus . International Journal of Food Microbiology, 40, 169-175.

Kitazawa H., Ishii Y., Uemura J., Kawai Y., Saito T., Kaneko T., Noda K., & Itoh T., 2000. Augmentation of macrophage functions by an extracellular phosphopolysaccharide from Lactobacillus delbrueckii ssp. bulgaricus . Food Microbiology, 17, 109-118.

Kitazawa H., Itoh T., Tomioka Y., Mizugaki M., & Yamaguchi T., 1996. Induction of IFN-γ and IL-1a production in macrophages stimulated with phosphopolysaccharide produced by Lactococcus lactis ssp. cremoris . International Journal of Food Microbiology, 31, 99-106.

Klein G., 2003. Use of molecular methods in food microbiology with the example of probiotic use of lactobacilli. Berl Munch Tierarztl Wochenschr, 116, 510-516.

Klinman D. M., Currie D., Gursel I., & Verthelyi D., 2004. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunological Reviews, 199, 201-216.

Knopf P. M., 2000. Immunomodulation and allergy. Allergy Asthma Proceedings, 21, 215-220.

Laas T., 1998. Isoelectric focusing. In Protein purification ; Janson, J.-C., Ryden, L., Eds. p. 495; Wiley: Toronto, Canada.

Labischinski H., & Maidhof H., 1994. Bacterial peptidoglycan: overview and evolving concepts. In J. M. Ghuysen and R. Hakenbeck , Bacterial Cell Wall , (pp. 23-38). Elsevier, Amsterdam, Hollande.

Laemmli U. K., 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 22, 680-685.

Lammers K. M., Brigidi P., Vitali B., Gionchetti P., Rizzello F., Caramelli E., Matteuzzi D., & Campieri M., 2003. Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunology and Medical Microbiology, 38, 165-172.

Lancaster M., & Fields R. D., 1996. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents. US patent #5501959.

Lauer E., & Kandler O., 1983. DNA-DNA homology, murein types and enzyme patterns in the type strains of the genus Bifidobacterium . Systematic and Applied Microbiology, 4, 42-64.

Le Y., Murphy P. M., & Wang J. M., 2002. Formyl-peptide receptors revisited. Trends in Immunology , 23, 541-548.

Lee J. W., Shin J. G., Kim E. H., Kang H. E., Yim I. B., Kim J. Y., Joo H. G. & Woo H. J., 2004. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum . Journal of Veterinary Sciences 5, 41-48 .

Li Q., & Magee W. E., 1993. An antibody adsorption technique facilitates antigen selection for development of serotype-specific monoclonal antibodies to Yersinia entercolitica . Biotechniques, 14, 962-970.

Lilly D. M., & Stillwell R. H., 1965. Probiotics: growth-promoting factors produced by microorganisms. Science, 147, 747-748 .

Lima-Filho J. V., Vieira L.Q., Arantes R. M., & Nicoli J. R., 2004. Effect of the Escherichia coli EMO strain on experimental infection by Salmonella enterica serovar Typhimurium in gnotobiotic mice. Brazilian Journal of Medical and Biological Research, 37, 1005-1013.

Lin H. C., Su B. H., Chen A. C., Lin T. W., Tsai C. H., Yeh T. F., & Oh W., 2005. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics, 115, 1-4.

Litvak D. A, Evers B. M., Hwang K. O., Hellmich M. R., Ko T. C., Townsend C. M., Jr., 1998. Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21Waf1/Cip1 and p27Kip1. Surgery, 124, 161-169.

Lodinova-Zadnikova R., Cukrowska B., & Tlaskalova-Hogenova H., 2003. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). International Archives of Allergy and Immunology, 131, 2009-2011.

Looijesteijn P. J., Trapet L., De vries E., Abee T., & Hugenholdz J., 2001. Physiological function of exopolysaccharides produced by Lactococcus lactis . International Journal of Food Microbilogy, 64, 71-80.

Macatonia S. E., Doherty T. M., Knight S. C., & O’Garra A., 1993. Differential effect of IL-10 on dentritic cell-induced T cell proliferation and IFN- production. Journal of Immunology, 150, 3755-3765.

Magnarelli L. A., Matthew Norris L., Steven J., & Fikrig E., 2002. Comparative reactivity of human sera to recombinant VisE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immnosorbant assays for Lyme borreliosis. Journal of Medicine and Microbiology, 51, 649-655.

Makelainen H., Tahvonen R., Salminen S., & Ouwehand A. C., 2003. In vivo safety assessment of two Bifidobacterium longum strains. Microbiology and Immunology, 47, 911-914.

Marasco W. A., Phan S. H., Krutzsch H., Showell H. J., Feltner D. E., Nairnll Becker R. E. L., & Ward P. A., 1984. Purification and identification of formyl-Methionyl-Leucyl-Phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. Journal of Biological Chemistry, 259, 5430-5439 .

Marelli G., Papaleo E., & Ferrari A., 2004. Lactobacilli for prevention of urogenital infections: a review. European Review of Medicine and Pharmacology Sciences, 8, 87-95.

Marin M. L., Lee J. H., Murtha J., Ustunol Z., & Pestika J. J., 1997. Differential cytokine production in clonal macrophage and T-cell lines cultured with Bifidobacteria. Journal of Dairy Science, 80, 2713-2720.

Markus S., Failing K., & Baumgartner W., 2002. Increased expression of pro-inflammatory cytokines and lack of up-regulation of anti-inflammatory cytokines in early distemper CNS lesions. Journal of Neuroimmunology, 125, 30-41.

Marteau P., & Vesa T., 1998. Pharmacokinetics of probiotics and biotherapeutic agents in humans. Bioscience Microflora, 17, 1-6.

Marteau P., & Shanahan F., 2003. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side effects. Best Practices & Research Clinical Gastroenterology ,17, 725-740.

Masco L., Ventura M., Zink R., Huys G., & Swings J., 2004 . Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov. International Journal of Systematic and Evolutionary Microbiology, 54, 1137-1143.

Mastrandrea F., Coradduzza G., Serio G., Minardi A., Manelli M., Ardito S., & Muratore L., 2004. Probiotics reduce the CD34 + hemopoietic precursor cell increased traffic in allergic subjects. Allergy and Immunology (Paris), 36, 118-122.

Matsuguchi T., Takagi A., Matsuzaki T., Nagaoka M., Ishikawa K., Yokokura T., & Yoshikai Y., 2003. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activitives in macrophages through toll-like receptor 2. Clinical and Diagnostic Laboratory Immunology, 10, 259-266.

Matsumoto M., & Benno Y., 2004. Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects. Mutation Research, 568, 147-153.

Matsuzaki T., & Chin J., 2000. Modulating immune response with probiotic bacteria. Immunology and Cell Biology, 78, 67-73 .

Matteuzzi D., Crociani F., Zani G. & Trovatelli L. D., 1971. Bifidobacterium suis n. sp.: a new species of the genus Bifidobacterium isolated from pig feces. Zeitschrift Fur Allgemeine Mikrobiologie, 11, 387-395.

Mattila-Sandholm T., Matto J., & Saarela M., 1999. Lactic acid bacteria with health claims- interaction and interference with gastrointestinal flora. International Dairy Journal, 9, 25-35.

Matto J., Malinen E., Suihko M. L., Alander M., Palva A., & Saarela1 M., 2004. Genetic heterogeneity and functional properties of intestinal bifidobacteria. Journal of Applied Microbiology, 97, 459-470.

McCarthy J., O'Mahony L., O'Callaghan L., Sheil B., Vaughan E. E., Fitzsimons N., Fitzgibbon J., O'Sullivan G. C., Kiely B., Collins J. K., & Shanahan F., 2003. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut,52, 975-980 .

McCracken V. J., & Lorenz R. G., 2001. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cellular Microbiology, 3, 1-11

McGuirk P., & Mills K. H.G., 2002. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends in Immunology, 23, 450-455.

McHeyzer-Williams L. J., & McHeyzer-Williams M. G., 2005. Antigen specific memory B cell development. Annual Review of Immunology, 23, 487-513.

Medzhitov R., Preston-Hurlburt P., & Janeway C. A. Jr, 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature, 388, 394-397.

Meile L., Rohr L. M., Geissmann T. A., Herensperger M., & Teuber M., 2001. Characterization of the D- xylulose 5 phosphate/ D-fructose 6-phosphate phosphoketolase gene (xfp) from Bifidobacterium lactis . Journal of Bacteriology, 183, 2929-2936.

Mercenier A., Pavan S., & Pot B., 2002. Probiotics as biotherapeutic agents: Present knowledge and future prospects. Current Pharmaceutical Design, 8, 99-110 .

Metchnikoff E., 1907. The prolongation of life. In Optimistic Studies (Heinemann W., Ed.), pp. 1-100. G. P. Putnam and Sons, London, UK.

Metzger H., 1970. Structure and function of gamma M macroglobulins. Advances in Immunology, 12, 57-116.

Meydani S. N., & Ha N. K., 2000. Immunological effects of yogourt. American Journal of Clinical Nutrition, 71, 861-872.

Mitsuoka T., 1969. Comparative studies on bifidobacteria isolated from the alimentary tract of man and animals incluing descriptions of Bifidobacterium thermophilum nov. spec. and Bifidobacterium pseudolongum nov. spec. Zentralblatt fur Bakteriologie, 210, 52-64.

Mitsuoka T., 1989. Microbes in the intestine. Ed. Yakult Honsha Co., Tokyo, Japan

Mitsuoka T., 1990. Bifidobacteria and their role in human health. Society for Microbiology, 288, 263-267.

Miyake T., Watanabe K., Watanabe T., & Oyaizu H., 1998. Phylogenetic analysis of the genus Bifidobacterium and related genera based on 16S rDNA sequences. Microbiology and Immunology, 42, 661-667.

Monteleone I., Vavassori P., Biancone L., Monteleone G., & Pallone F., 2002. Immunoregulation in the gut: success and failures in human disease. Gut, 50, 60-64.

Moore W. E. C., & Holdeman L. V., 1974. Human faecal flora: the normal flora of 20 Japanese-Hawaiians. Applied Microbiology, 27, 961-979.

Moreillon P., & Majcherczyk P. A., 2003. Proinflammatory activity of cell-wall constituents from Gram-positive bacteria. Scandinavian Journal of Infectious Diseases, 35, 632-641.

Morita H., He F., Fuse T., Ouwehand A. C., Hashimoto H., Hosoda M., Mizumachi K., & Kurisaki J. I., 2002. Cytokine production by the murine macrophage cell line J774.1 after exposure to lactobacilli. Bioscience, Biotechnology and Biochemistry, 66,1963-1966.

Mortensen P. B., & Clausen M. R., 1996. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scandinavian Journal of Gastroenterology, 216, 132-148.

Mosmann T. R., & Coffman R. L., 1989. Th1 and Th2 cells. Different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology, 7, 145-173.

Mullié C., Yazourth A., Singer E., Lecroix F., Blareau J. P., Romond M. B., & Romond C., 2002. Partial characterization of Bifidobacterium breve C50 cell-free whey compounds inducing modifications to the intestinal microflora. Journal of Dairy Science, 85, 1383-1389.

Nader de Macìas M. E., Apella M. C., Romero N. C., González S. N., & Oliver G., 1992. Inhibition of Shigella sonnei by Lactobacillus casei and Lactobacillus acidophilus . Journal of Applied Bacteriology, 73, 407-411.

Nast C. C., & LeDuc L. E., 1988. Chemotactic peptides. Mechanisms, functions, and possible role in inflammatory bowel disease. Digestive and Disease Sciences, 33, 50- 57.

Neurath M. F., Finotto S., & Glimcher L. H., 2002. The role of Th1/Th2 polarization in mucosal immunity. Nature Medicine, 8, 567-573.

Neumann E., Oliveira M. A., Cabral C. M., Moura L. N., Nicoli J. R., Vieira E. C., Cara D. C., Podoprigora G. I., & Vieira L. Q., 1998. Monoassociation with Lactobacillus acidophilus UFV-H2b20 stimulates the immune defense mechanisms of germfree mice. Brazilian Journal of Medical and Biological Research, 31, 1565-1573.

Nishimura-Uemura J., Kitazawa H., Kawai Y., Itoh T., Oda M., & Saito T., 2003. Functional alteration of murine macrophages stimulated with extracellular polysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. Food Microbiology, 20, 267-273.

Nouaille S., Ribeiro L. A., Miyoshi A., Pontes D., Le Loir Y., Costa Oliveira S., Langella P., & Azevedo V., 2003. Heterologous protein production and delivery systems for Lactococcus lactis . Genetics and Molecular Research, 2, 102-111.

Noverr M. C., & Huffnagle1 G. B., 2004. Does the microbiota regulate immune responses outside the gut? Trends in Microbiology, 12, 562-568.

Oda M., Hasegawa H., Komatsu S., Kambe M., & Tsuchiya F., 1983. Anti-tumor polysaccharide from Lactobacillus sp.. Agricultural and Biological Chemistry, 47, 1623-1625.

Ogawara H., Handa H., Yamazaki T., Toda T., Yoshida K., Nishimoto N., & Al-Ma'quol, 2005. High Th1/Th2 ratio in patients with multiple myeloma. Leukemia Reserach, 29, 135-140.

Ollier William E. R., 2004. Cytokine genes and disease susceptibility. Cytokine, 28, 174-178.

Orla-Jensen S., 1924. La classification des bactéries lactiques. Lait 4, 468-474 .

Ouwehand A. C., & Vesterlund S., 2003. Health aspects of probiotics. Drugs, 6, 573-580.

Ouwehand A. C., Kirjavainen P. V., Gronlund M. M., Isolauri S. J., & Salminen S., 1999. Adhesion of probiotic microorganisms to intestinal mucus. International Dairy Journal, 9, 623-630.

Ouwehand A., Isolauri E., & Salminen S., 2002. The role of the intestinal microflora for the development of the immune system in early childhood. European of Journal Nutrition, 41, 32- 37.

Panaro M. A., & Mitolo V., 1999. Cellular responses to FMLP challenging: a mini-review. Immunopharmacology and Immunotoxicology, 21, 397-419.

Parker R. B., 1974. Probiotics, the other half of the antibiotic story. Animal Nutrition and Health, 29, 4-8.

Pathmakanthan S., Li C. K., Cowie J., & Hawkey C. J., 2004. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon. Journal of Gastroenterology and Hepatology, 19, 166-173.

Pavan S., Desreumaux P., & Mercenier A., 2003. Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clinical and Diagnostic Laboratory Immunology, 10, 696-701.

Peeters T., & Vantrappen G., 1975. The paneth cell: a source of intestinal lysozyme. Gut, 16, 553-558.

Perdigon G., Fuller R., & Raya R., 2001. Lactic acid bacteria and their effect on the immune system. Current Issues Intestinal Microbiology, 2, 17-42.

Perdigon G., Locascio M., Medici M., Pesce de Ruiz Holgado A., Oliver G., 2003. Interaction of bifidobacteria with the gut and their influence in the immune function. Biocell, 27, 1-9.

Perdigon G., Maldonado Galdeano C., Valdez J. C., Medici M., 2002. Interaction of lactic acid bacteria with the gut immune system. European Journal of Clinical Nutrition, 56, 21-26.

Pessi T., Sütas Y., Saxelin M., Kallioinen H., & Isolauri E., 1999. Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Applied and Environmental Microbiology, 65, 4725-4728.

Pestka J. J., Ha C. L., Warner R. W., Lee J. H., & Ustunol Z., 2001. Effects of ingestion of yogurts containing Bifidobacterium and Lactobacillus acidophilus on spleen and Peyer's patch lymphocyte populations in the mouse. Food Protection., 64, 392-395.

Pfeifer A., & Rosat J. P., 2000. Probiotics in alimentation: clinical evidence for their enhancement of the natural immunity of the gut. In Probiotics, other nutritional factors and intestinal microflora . Lippincott-Raven , (pp. 243-257), Philadelphia.

Plummer S., Weaver M. A., Harris J. C., Dee P., & Hunter J., 2004. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. International Microbiology, 7, 59-62.

Prasad J., McJarrow P., & Gopal, P., 2003. Heat and osmotic stress responses of probiotic Lactobacillus rhamnosus HN001 (DR20) in relation to viability after drying. Applied and Environmental Microbiology, 69, 917-925.

Prioult, G., Fliss, I., & Pecquet, S., 2003. Effect of probiotic bacteria on induction and maintenance of oral tolerance to β-lactoglobulin in gnotobiotic mice. Clinical Diagnostic and Laboratory Immunology, 10, 787-792.

Pulendran B., 2004. Modulating Th1/Th2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunology Research., 29, 187-196.

Pyo C. W, Hur S. S., Kim Y. K., Choi H. B., Hong Y. S., Kim D. W., Kim C. C., Kim H. K., & Kim T. G., 2003. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-gamma genes in the Korean population. Human Immunology, 64, 979-989.

Rangavajhyala N., Shahani M., Sridevi G., & Srikumaran S., 1997. Nonlipopolysaccharide component(s) of Lactobacillus acidophilus stimulate(s) the production of interleukin-1 alpha and tumor necrosis factor-alpha by murine macrophages. Nutrition and Cancer, 28, 130-134.

Rastall R. A., 2004. Bacteria in the gut: Friends and foes and how to alter the balance. Journal of Nutrition, 134, 2022-2026.

Reddy B. S., & Rivenson A., 1993. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3-methylimidazo (4,5-f) quinoline, a food mutagen. Cancer Research, 53, 3914-3918.

Reid G., & Burton J., 2002. Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes and Infection, 4, 319-324.

Reid G., Charbonneau D., Erb J., Kochanowski B., Beuerman D., Poehner R., & Bruce A. W., 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology, 35, 131-134.

Reid G., Siang Gan B., She Y. M., Ens W., Weinberger S., & Howard J. C., 2002. Rapid identification of probiotic Lactobacillus biosurfactant proteins by proteinchip tandem mass spectrometry tryptic peptide sequencing. Applied and Environmental Microbiology, 68, 977-980.

Report of FAO/WHO, 2002. Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. London Ontario, Canada, April 30 and May 1, pp 1-11.

Ricciardi A., & Clementi F., 2000. Exopolysaccharides from lactic acid bacteria: structure, production and technological applications. Italian Journal of Food Science, 12, 23-45.

Rinkinena M., Jalavab K., Westermarcka E., Salminenc S., & Ouwehand A. C., 2003. Interaction between probiotic lactic acid bacteria and canine enteric pathogens: a risk factor for intestinal Enterococcus faecium colonization? Veterinary Microbiology, 92, 111-119.

Roberts C. M., Fett W. F., Osman S. F., Wijey C., O’Connor J. V., & Hoover D.G., 1995. Exopolysaccharide production by Bifibobacterium longum BB-79. Journal of Applied Bacteriology, 78, 463-468.

Robinson D. S., 2004. T-cell cytokines: what we have learned from human studies. Paediatric respiratory reviews, 5, 53-58.

Rolfe R. D., 2000. The role of probiotic cultures in the control of gastrointestinal health. Journal of Nutrition, 130, 396- 402.

Romagnani S., 2004. Immunologic influences on allergy and the Th1/Th2 balance. Jounal of Allergy and Clinical Immunology, 113, 395-400.

Roman M., Martin-Orozco E., Goodman J. S., Nguyen M. D., Sato Y., Ronaghy A., Kornbluth R. S., Richman D. D., Carson D.A., & Raz E., 1997. Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants. Nature Medicine, 3, 849-854.

Rook G.A., & Brunet L. R., 2005. Microbes, immunoregulation, and the gut. Gut, 54, 317-20.

Rosenfeldt V., Benfeldt E., Valerius N. H., Paerregaard A., & Michaelsen K. F., 2004. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. Journal of Pediatry, 145, 612-616.

Rosenfeldt V., Michaelsen K. F., Jakobsen M., Larsen C.N., Moller P. L., Pedersen P., Tvede M., Weyrehter H., Valerius N. H., Paerregaard A., 2002. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea. Pediatry and Infectious Diseases Journal, 21, 411-416.

Ruas-Madiedo P., Hugenholtz J., & Zoon P., 2002. An overview of the functionality of exopolysaccharides produced by lactic acid bacteria. International Dairy Journal, 12, 163-171.

Ruiz-Bravo A., Jimenez-Valera M., Moreno E., Guerra V., & Ramos-Cormenzana A., 2001. Biological response modifier activity of an exopolysaccharide from Paenibacillus jamilae CP-7. Clinical and Diagnostic Laboratory Immunology, 8, 706-710.

Saarela M., Mogensen G., Fondén R., Matto J., & Mattila-Sandholm T., 2000. Probiotic bacteria: safety, functional and technological properties. Journal of Biotechnology, 84, 197-215.

Saavedra J. M, & Tschernia A., 2002. Human studies with probiotics and prebiotics: clinical implications. British Journal of Nutrition, 87, 241-246.

Saito T., 2004. Selection of useful probiotic lactic acid bacteria from the Lactobacillus acidophilus group and their applications to functional foods. Animal Science Journal, 75, 1-13.

Salmimen S., Von Wright A., Morelli L., Marteau P., Brassard D., de vos W. M., Fonden R., Saxelin M., Collins K., Mogensen G., Birkeland S. E., & Mattila Sandholm T., 1998. Demonstration of safety of probiotics- a review. International Journal of Food Microbiology, 44, 93- 106.

Salminen S., Isolauri E., & Salminen, E., 1996. Clinical uses of probiotics for stablising gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 70, 347-358.

Samartsev A. A., Astapovich N. I., & Novik G. I., 2000. Production of cell-wall-bound proteinases in Bifidobacterium adolescentis 94-BIM. Microbiology, 69, 655-658.

Sanders M. E., 2000. Considerations for use of probiotic bacteria to modulate human health. Journal of Nutrition, 130, 384-390.

Saxelin M., Pessi T., & Salminen S., 1995 . Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. International Journal of Food Microbiology, 25, 199-203.

Scardovi V., & Trovatelli L. D., 1974. Bifidobacterium animalis (Mitsuoka) comb. nov. and the ‘minimum’ and ‘subtile’ groups of new bifidobacteria found in sewage. International Journal of Systematic Bacteriology, 24, 21-28.

Scardovi V., 1984. Genus Bifidobacterium Orla-Jensen, 1924, 472, p. 1418-1434. In Bergey’s manual of systematic bacteriology . Krieg N.R. and Holt J.G. (eds), , Vol. 1. Williams and Wilkins, Baltimore, Md, USA.

Schiffmann E., Showell H. J., Corcoran B. A., Ward P. A., Smith E., & Becker E. L., 1975. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli . Journal of Immunology, 114, 1831- 1837 .

Schiffrin E. J., & Blum S., 2002. Interactions between the microbiota and the intestinal mucosa. European Journal of Clinical Nutrition, 56, 60-64.

Schloter M., Assmus B., & Hartmann A., 1995. The use of immunological methods to detect and identify bacteria in the environment. Biotechnology Advances, 13, 75-90 .

Schrezenmeir J., & de Vrese M., 2001. Probiotics, prebiotics, and synbiotics-approaching a definition. American Journal of Clinical Nutrition, 73, 361- 364.

Schultz M., Linde H. J., Lehn N., Zimmermann K., Grossmann J., Falk W., & Scholmerich J., 2003. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. Journal of Dairy Research,70, 165-173.

Screekumar O., & Hosono A., 1998. The antimutagenic properties of a polysaccharide produced by Bifibobacterium longum and its cultured milk against some heterocyclic amines. Canadian Journal of Microbiology, 44, 1029-1036.

Sgouras D., Maragkoudakis P., Petraki K., Martinez-Gonzalez B., Eriotou E., S. Michopoulos, Kalantzopoulos G., Tsakalidou E., & Mentis A., 2004. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain s hirota . Applied and environmental microbiology, 70, 518-526.

Shah N. P., 2000. Probiotic bacteria: selective enumeration and survival in dairy foods. Journal of Dairy Sciences, 83, 894-907.

Sheikh A., & Strachan D., 2004. The hygiene theory: fact or fiction? . Current Opinion in Otolaryngology & Head & Neck Surgery, 12, 232-236.

Sherwood L., & Gorbach M. D., 2000. Probiotics and gastrointestinal health. American Journal of Gastroenterology, 95, 1-4.

Shu Q., Lin H., Rutherfurd K. J., Fenwick S. G., Prasad J., Gopal P. K., & Gill H. S., 2000. Dietary Bifidobacterium lactis (HN019) enhances resistance to oral Salmonella typhimurium infection in mice. Microbiology and Immunology, 44, 213-222.

Simons C. D., Ciardi A., Grassi A., Gardini S. L., Tzantzoglou S., Trinchieri V., Moretti S., & Jirillo E., 1992. Effect of Bifibobacterium bifidum and Lactobacillus acidophilus of gut mucosa and peripheral blood B lymphocytes. Immunopharmacology and Immunotoxicology, 14, 333-340.

Simpson P. J., Stanton C., Fitzgerald G. F. & Ross R. P., 2003. Genomic diversity and relatedness of bifidobacteria isolated from a porcine cecum. Journal of Bacteriology, 185, 2571-2581.

Spahn T. W., & Kucharzik T., 2004. Modulating the intestinal immune system: The role of lymphotoxin and galt organs. Gut, 53, 456-465.

Spellberg B., & Edwards J. E., 2001. Type 1/Type 2 immunity in infectious diseases. Clinical Infectious Diseases, 32, 76-102.

Sreekumar, O., & Hosono A., 1998. The antimutagenic properties of a polysaccharide produced by Bifibobacterium longum and its cultured milk against some heterocyclic amines. Canadian Journal of Microbiology, 44, 1029-1036.

Standford T. J., Arenberg D. A, Danforth J. M., Kunkel S. L., Van Otteren G. M., & Strieter R. M., 1994. Lipoteichoique acid induces secretion of interleukin-8 from human blood monocytes: a cellular and molecular analysis. Infection and Immunity, 62, 119-125.

Stanton C., Gardiner G., Meehan H., Collins K., Fitzgerald G., Lynch P. B., & Ross R . P., 2001. Market potential for probiotics. American Journal of Clinical Nutrition, 73, 476- 483.

Stingele F., Corthesy B., Kusy N., Porcelli S. A., Kasper D. L., & Tzianabos A. O., 2004. Zwitterionic polysaccharides stimulate T cells with no preferential V{beta} usage and promote anergy, resulting in protection against experimental abscess formation. Journal of Immunology, 172, 1483-1490.

Sullivan A., & Nord C. E., 2002. The place of probiotics in human intestinal infections. International Journal of Antimicrobial Agents, 20, 313-319.

Sullivan A., & Nord C. E., 2005. Probiotics and gastrointestinal diseases. Journal of Internal Medicine, 257, 78-92.

Sun J., Walsh M., Villarino A. V., Cervi L., Hunter C. A., Choi Y., & Pearce E. J., 2005. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. Immunology, 174, 742-751.

Sun S., Zhang X., Tough D. F., & Sprent J., 1998. Type I interferon-mediated stimulation of T cells by CpG DNA. Journal of Experimental Medicine, 188, 2335-2342.

Svensson L., Dahlgren C., & Wenneras C., 2002. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. Journal of Leukocyte Biology, 72, 810-818.

Swain S. L., 1993. IL-4 dictates T-cell differentiation. Research in Immunology, 144, 616-620.

Takeuchi O., Hoshino K., & Akira S., 2000. Cutting edge: TLR2-deficient and MyD88- deficient mice are highly susceptible to Staphylococcus aureus infection. Journal of Immunology, 165, 5392-5396.

Tan Y. J, Zhang Y. B., Feng D. Y., Xie B., Lin Z.Y., Chen H. G., & Li Y. G., 2004. The change and the clinical significance of peripheral blood Th1/Th2 cells in patients with pulmonary tuberculosis. Zhonghua Jie He He Hu Xi Za Zhi, 27, 385-389.

Tanaka K., & Ishikawa H., 2004. Role of intestinal bacterial flora in oral tolerance induction. Histology and Histopathology, 19, 907-914.

Tang X. L., Peppler M. S., Irvin R. T., & Suresh M. R., 2004. Use of bispecific antibodies in molecular velcro assays whose specificity approaches the theoretical limit of immunodetection for Bordetella pertussis . Clinical Diagnostic and Laboratory Immunology, 11, 752-757.

Tannock G. W., 1999a. The normal microflora: an introduction. In Medical importance of normal microflora. Tannock, G. W., Ed., pp. 1-23, Kluwer Academic Publishers, London, UK.

Tannock G. W., 1997. Probiotic properties of lactic-acid bacteria: plenty of scope for fundamental R & D. Trends in Biotechnology, 15, 270-274.

Tannock G. W., 1999b. Analysis of the intestinal microflora: a renaissance. Antonie Van Leeuwenhoek. 76, 265-278.

Tannock G. W., Munro K., Bibiloni R., Simon M. A., Hargreaves P., Gopal P., Harmsen H., & Welling G., 2004. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Applied and Environmental Microbiology, 70, 2129-2136.

Tejada-Simon M. V., & Pestka J. J., 1999. Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria. Journal of Food Protection, 62, 1435-1444.

Till S. J., Francis J. N., Nouri-Aria K., F. R. C. Path, & Durham S. R., 2004. Mechanisms of immunotherapy. Journal of Allergy and Clinical Immunology, 113, 1025-1034.

Tlaskalová-Hogenová H., Štepánková R., Hudcovic T., Tucková L., Cukrowskab B., Lodinová-Žádnıková R., Kozáková H., Rossmanna P., Bártová J., Sokol D., Funda D. P., Borovská D., Reháková Z., Šinkora J., Hofmana J., Drastich P., & Kokešová A., 2004. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. Immunology Letters, 93, 97-108.

Tobian A. A., Canaday D. H., Boom W. H., & Harding C. V., 2004. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8 + T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. Journal of Immunology, 172, 5277-5286.

Tomasî icâ J., Dujmovicâ I. H., Ï poljar B., Vranesi icâ B., Ï antak M. S., & Jovici icâ A., 2000. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in the mouse. Vaccine,18, 1236-1243.

Tone-Shimokawa Y., Toida T., & Kawashima T., 1996. Isolation and structural analysis of polysaccharide containing galactofuranose from the cell walls of Bifidobacterium infantis . Journal of Bacteriology, 178, 317-320.

Touré R., Kheadr E., Lacroix C., Moroni O., & Fliss I., 2003. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes . Journal of Applied Microbiology, 95, 1058-1069.

Townsend M. J., & McKenzie A. N., 2000. Unravelling the net ? cytokines and diseases. Journal of Cell Sciences, 113, 3549-3550.

Trindade C. S. F., & Grosso C. R. F., 2000. The effect of the immobilisation of Lactobacillus acidophilus and Bifidobacterium lactis in alginate on their tolerance to gastrointestinal secretions. Milchwissenschaft-Milk Science International, 55, 496-499.

Tuinier R., van Casteren W. H. M., Looijesteijn P. L., Schols H. A., Voragen A. G. J., & Zoon P., 2001. Effects of structural modifications on some physical characteristics of exopolysaccharides from Lactoccus lactis . Biopolymers, 59, 160-166.

Turchet P., Laurenzano M., Auboiron S., & Antoine J. M., 2003. Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomised, controlled pilot study. Journal of Nutrition and Health Aging, 7, 75-77.

Tursi A., Brandimarte G., Giorgetti G. M., & Modeo M. E., 2004. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Medical Science Monitor, 10, 662-666.

Tzianabos A. O., Finberg R. W., Wang Y., Chan M., Onderdonk A. B., Jennings, H. J., & Kasper D. L., 2000. T cells activated by zwitterionic molecules prevent abscesses induced by pathogenic bacteria. Journal of Biological Chemistry, 275, 6733.

Tzianabos A. O., Wang J. Y., & Kasper D. L., 2001. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proceedings of the National Academy Science of USA, 98, 9365.

Tzianabos A., Wang J. Y., & Kaspera D. L., 2003. Biological chemistry of immunomodulation by zwitterionic polysaccharides. Carbohydrate Research, 338, 2531-2538.

Ulisse S., Gionchetti P., D’Alo S., Paola Russo F., Pesce I., Ricci G., Rizzello F., Helwig U., Grazia Cifone M., M. Campieri, & De Simone C., 2001. Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: Effects of probiotic treatment. The americain Journal of Gastroenterology, 96, 2691-2699.

Valentini G., Baroni A., Esposito K., Naclerio C., Buommino E., Farzati A., Cuomo G., & Farzati B., 2001. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. Journal of Clinical Immunology, 21, 210-217.

Valeur N., Engel P., Carbajal N., Connolly E., & Ladefoged K., 2004. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Applied and Environmental Microbiology, 70, 1176-1181.

van Amelsfort J. M, Jacobs K. M, Bijlsma J. W., Lafeber F. P., & Taams L. S., 2004. CD4 +CD25 + regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheumatism., 50, 2775-2785.

Van Calsteren M. R., Pau-Roblot C., Begin A., & Roy D., 2002. Structure determination of the exopolysaccharide produced by Lactobacillus rhamnosus strains RW-9595M and R. Biochemical Journal, 363, 7-17.

Vaningelgem F., Zamfir M., Mozzi F., Adriany T., Vancanneyt M., Swings J., De Vuyst L., 2004. Biodiversity of exopolysaccharides produced by Streptococcus thermophilus strains is reflected in their production and their molecular and functional characteristics. Applied and Environmental microbiology, 70, 2900-2912.

Varcoe J. J., Krejcarek G., Busta F., & Brady L., 2003. Prophylactic feeding of Lactobacillus acidophilus NCFM to mice attenuates overt colonic hyperplasia. Journal of Food Protection, 66, 457-465.

Velazquez P., Wei B., & Braun J., 2004. Surveillance B lymphocytes and mucosal immunoregulation. Springer Seminars in Immunopathology, Dec 18 (Epub ahead of print).

Ventura M., van Sinderen D., Fitzgerald G. F., & Zink R., 2004. Insights into the taxonomy, genetics and physiology of bifidobacteria. Antonie van Leeuwenhoek,86, 205-223.

Verdu E. F, Bercik P., Bergonzelli G. E., Huang X. X., Blennerhasset P., Rochat F., Fiaux M., Mansourian R., Corthesy-Theulaz I., & Collins S. M., 2004 Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction. Gastroenterology, 127, 826-837.

Vermont C. L., Dijken H. H van., Kuipers A. J., Limpt C. J. P. Van, Keijzers W. C. M., Ende A. van der, Groot R. de, Alphen L. van, & van den Dobbelsteen G. P. J. M., 2003. Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine. Infection and immunity, 71, 1650-1655.

Villarino A. V., Huang E., & Hunter C. A., 2004. Understanding the pro- and anti-inflammatory properties of IL-27. Immunology, 173, 715-720.

Vinderola C. G, Medici M., & Perdigon G., 2004. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. Journal of Applied Microbiology, 96, 230-43.

Vitali B., Candela M., Matteuzzi D., & Brigidi P., 2003. Quantitative detection of probiotic Bifidobacterium strains in bacterial mixtures by using real-time PCR. Systematic and Applied Microbiology, 26, 269-276.

Von der Weid T., Ibnou-Zekri N., & Pfeifer A., 2002. Novel probiotics for the management of allergic inflammation. Digestive and Liver disease, 349, 25-28.

Von Heijne G., 1990. The signal peptide. Journal of Membrane Biology, 115, 195-201 .

Wallinder I. B., & Neujahr H. Y., 1971. Cell wall and peptidoglycan from Lactobacillus fermenti. Journal of bacteriology, 105, 918-926.

Wang J. E., Dahle M. K., McDonald M., Foster S. J., Aasen A. O., & Thiemermann C., 2003. Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism. Shock, 20, 402-414 .

Wang J. L., Kang L., & Jia H. L., 2004. Generation and characterization of monoclonal antibodies against Botulinum neurotoxin type A (BoNT/A). Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 20, 83-85.

Wang M. F., Lin H. C., Wang Y. Y., & Hsu C. H., 2004. Treatment of perennial allergic rhinitis with lactic acid bacteria. Pediatric Allergy and Immunology, 15, 152-158.

Wang X., Brown I. L., Evans A. J., & Conway P. L., 1999. The protective effects of high amylose maize (amylomaize) starch granules on the survival of Bifidobaterium spp. in the mouse intestinal tract. Journal of Applied Microbiology, 87, 631-639.

Wang P. H., Hsu C. I., Tang S. C., Huang Y. L., Lin J. Y., & Ko J. L., 2004. Fungal immunomodulatory protein from Flammulina velutipes induces interferon-gamma production through p38 mitogen-activated protein kinase signaling pathway. Journal of Agricultural and Food Chemistry, 52, 2721-2725.

Ward P. A., Lepow I. H., & Newman L. J., 1968. Bacterial factors chemotactic for polymorphonuclear leukocytes. American Journal of Pathology, 52, 725-736.

Weintraub A., 2003. Immunology of bacterial polysaccharide antigens. Carbohydrate Research, 338, 2539-2547.

Welman A. D., & Maddox I. S., 2003. Exopolysaccharides from lactic acid bacteria: perspectives and challenges. Trends in Biotechnology, 21, 269-274.

Whitfield C., & Valvano M. A, 1993. Biosynthesis and expression of cell-surface polysaccharides in gram-negative bacteria. Advances in Microbiology and physiology, 35, 135-146.

Yamamoto A., Usami H., Nagamuta M., Sugawara Y., Hamada S., Yamamoto T., Kato K., Kokeguchi S., & Kotani S., 1985. The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis. British Journal of Cancer, 51, 739-742.

Yamazaki S., Machii K., Tsuyuki S., Momose H., Kawashima T., & Ueda K, 1985. Immunological responses to monoassociated Bifidobacterium longum and their relation to prevention of bacterial invasion. Immunology, 56, 43-50.

Yamazaki S., Tsuyuki S., Akashiba H., Kamimura H., Kimura M., Kawashima T., & Ueda K., 1991. Immune response of Bifidobacterium -monoassociated mice. Bifidobacteria Microflora, 10, 19-31.

Yan F., & Polk D. B., 2002. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. The journal of biological chemistry, 27, 50959-50965.

Yasui H., Shida K., Matsuzaki T., & Yokokura T., 1999. Immunomodulatory function of lactic acid bacteria. Antoine Leewenhoekn international journal of general and molecular Microbiology, 76, 383-38.

Yazdanbakhsh M., & Rodrigues L. C., 2001. Allergy and the hygiene hypothesis: the Th1/Th2 counterregulation can not provide an explanation. Wiener Klinische Wochenschrift, 113, 899-902.

Yildirim Z., & Johnson M. G., 1998. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. Journal of Food Protection, 61, 47-51.

Zachariae C. O., Jinquan T., Nielsen V., Kaltoft K., & Thestrup-Pedersen K., 1992. Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP, IL-8, human IL-10, and epidermal lymphocyte chemotactic factor. Archives of Dermatology Research, 284, 333-338.

Zarate S., & Lopez-Leiva M. H., 1990. Oligosaccharide formation during enzymatic lactose hydrolysis: a literature review. Journal of Food Protection, 53, 262-268.

Zoetendal E. G., Collier C. T., Koike S., Mackie R. I., & Askins H. R., 2004. Molecular ecological analysis of the gastrointestinal microbiota: A review. Journal of Nutrition, 134, 465-472.

© Tahar Amrouche, 2005